| - SMTL ID
- 1py2.1
- Ligands
- 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID
- Polypeptides
- Interleukin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 1py2.2
- Ligands
- ZINC ION; 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID
- Polypeptides
- Interleukin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 1py2.3
- Ligands
- ZINC ION; 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID
- Polypeptides
- Interleukin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 1py2.4
- Ligands
- 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID
- Polypeptides
- Interleukin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 1py2.5
- Ligands
- ZINC ION; 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID
- Polypeptides
- Interleukin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 1py2.6
- Ligands
- ZINC ION; 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID
- Polypeptides
- Interleukin-2
- Oligo-state
- monomer
|